Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 643-647

  Landay, Melanie ^a   Huang, Andy ^a   Azziz, Ricardo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

17 hydroxyprogesterone; DHEAS; hair; hirsutism; Polycystic ovary syndrome; testosterone

Indexed keywords

ANDROGEN; HYDROXYPROGESTERONE; INSULIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROGENS; COMORBIDITY; FEMALE; HIRSUTISM; HUMANS; HYPERINSULINISM; INSULIN; LOS ANGELES; POLYCYSTIC OVARY SYNDROME; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 67651121847     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.021     Document Type: Article

References (18)

1. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2745-2749
2. Azziz R., Sanchez L.A., Knochenhauer E.S., Moran C., Lazenby J., Stephens K.C., et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89 (2004) 453-462
3. Chang W.Y., Knochenhauer E.S., Bartolucci A.A., and Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 83 (2005) 1717-1723
4. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome; toward a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston 377-384
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
6. Archer J., and Chang R.J. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18 (2004) 737-754
7. Reingold S.B., and Rosenfeld R.L. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol 123 (1987) 209-212
8. Guyatt G., Weaver B., Cronin L., Dooley J.A., and Azziz R. Health-Related Quality of Life in Women With Polycystic Ovary Syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 57 (2004) 1279-1287
9. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
10. Boots L.R., Potter S., Potter H.D., and Azziz R. Measurement of total serum testosterone level using commercial kits: high degree of variability and in accuracy. Fertil Steril 69 (1997) 286-292
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologica 28 (1985) 412-419
12. Singh A., Hamilton-Fairly D., Koistinen R., Seppala M., James V.H., Franks S., et al. Effect of insulin-like growth factor-type I (IGF-1) and insulin on the secretion of sex hormone binding globulin and IGF-1 binding protein (IBP-1) by human hepatoma cells. J Endocrinol 124 (1990) R1-R3
13. Weger N., and Schlake T. IGF-1 signaling controls the hair growth cycle and the differentiation of hair shafts. J Invest Dermatol 125 (2005) 873-882
14. Philpott M.P., Sanders D.A., and Kealey T. Whole hair follicle culture. Dermatol Clin 14 (1996) 595-607
15. Amato M.C., Galluzzo A., Merlino S., Mattina A., Richiusa P., Criscimanna A., et al. Lower insulin sensitivity differentiates hirsute from nonhirsute Sicilian women with polycystic ovary syndrome. Eur J Endocrinol 155 (2006) 859-865
16. Unluhizarci K., Karababa Y., Bayram F., and Kelestimur F. The investigation of insulin resistance in patients with idiopathic hirsutism. J Clin Endocrinol Metab 89 (2004) 2741-2744
17. Goodarzi M.O., Shah N.A., Antoine H.J., Pall M., Guo X., and Azziz R. Variants in the 5α-Reductase Type 1 and Type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 91 (2006) 4085-4091
18. Deplewski D., and Rosenfield R.L. Role of hormones in pilosebaceous unit development. Endocr Rev 21 (2000) 363-392